Rahul Banerjee’s perspectives on approval of daratumumab and hyaluronidase plus VRd in MM

Oncology Data Advisor shared on X:

“Did you hear about last week’s approval of daratumumab and hyaluronidase plus VRd as ASCT induction and consolidation for newly diagnosed multiple myeloma (NDMM)?

Read Rahul Banerjee’s perspectives and comment your thoughts below!”